# CYP8B1

## Overview
CYP8B1 is a gene that encodes the enzyme cytochrome P450 family 8 subfamily B member 1, also known as sterol 12α-hydroxylase. This enzyme is a member of the cytochrome P450 superfamily, which is characterized by its role in catalyzing the oxidation of organic substances. Specifically, CYP8B1 is involved in the biosynthesis of bile acids, where it catalyzes the 12α-hydroxylation of 7α-hydroxy-4-cholesten-3-one, a critical step in the conversion of cholesterol to cholic acid (Zhong2022Haploinsufficiency; Nebert2013Human). The activity of this enzyme is crucial for maintaining the balance of bile acids, which in turn affects cholesterol solubility and dietary lipid absorption (Gåfvels1999Structure; Wang2005Human). CYP8B1 is predominantly expressed in the liver and is regulated by various physiological conditions, including nutritional and hormonal states (Wang2005Human). The gene is notable for being intronless, which may facilitate efficient transcription (Gåfvels1999Structure). Alterations in CYP8B1 expression or function have been linked to metabolic disorders and liver diseases, highlighting its clinical significance (Wang2019Identification; Zhong2022Haploinsufficiency).

## Structure
The human CYP8B1 protein sequence exhibits a high degree of homology with mouse and rabbit sequences, showing 74.5% and 77.4% residue identity, respectively (Gåfvels1999Structure). The protein contains functional segments for oxygen binding, steroidogenic activity, and heme binding, which are highly conserved across species (Gåfvels1999Structure). The N-terminal region is hydrophobic and predicted to be membrane-spanning, although other predicted membrane-spanning segments were ruled out due to their location in the tertiary structure (Gåfvels1999Structure). The tryptophan residues are mostly conserved, while cysteine residues vary, with the human sequence containing four cysteines (Gåfvels1999Structure).

The gene is intronless, as confirmed by PCR analysis, and the main transcript size is approximately 2.1-2.2 kb (Gåfvels1999Structure). The human CYP8B1 gene, when expressed in COS-7 cells, produces an enzyme capable of hydroxylating 7α-hydroxy-4-cholesten-3-one at the 12α position, similar to the activity observed in human and rabbit liver microsomes (Gåfvels1999Structure). The protein's tertiary structure includes a heme-binding domain, typical of cytochrome P450 enzymes, although specific details on the secondary, tertiary, or quaternary structures are not provided in the available context. No information on post-translational modifications or splice variant isoforms is available (Gåfvels1999Structure).

## Function
The human gene CYP8B1 encodes the enzyme sterol 12α-hydroxylase, which plays a crucial role in bile acid synthesis. This enzyme is responsible for the 12α-hydroxylation of 7α-hydroxy-4-cholesten-3-one, a key step in the conversion of cholesterol to cholic acid, one of the primary bile acids (Zhong2022Haploinsufficiency; Nebert2013Human). The activity of CYP8B1 is essential for determining the ratio of cholic acid to chenodeoxycholic acid in bile, which influences the solubility of cholesterol and the absorption of dietary lipids in the intestine (Gåfvels1999Structure; Wang2005Human).

CYP8B1 is expressed exclusively in the liver, where it is distributed homogeneously in hepatocytes (Wang2005Human). The enzyme's activity is regulated by physiological conditions such as starvation and thyroid function, although specific regulatory elements for these conditions have not been identified (Gåfvels1999Structure). The balance of bile acids produced by CYP8B1 also affects cholesterol homeostasis and has implications for metabolic processes, such as insulin sensitivity (Zhong2022Haploinsufficiency). The gene is intronless, which is unusual for eukaryotic genes, potentially allowing for more efficient transcription (Gåfvels1999Structure).

## Clinical Significance
Mutations and alterations in the CYP8B1 gene have been associated with various metabolic conditions, particularly those related to insulin sensitivity and cardiovascular risk. Carriers of complete loss-of-function (CLOF) mutations in CYP8B1 exhibit increased insulin sensitivity, as evidenced by lower fasting insulin levels and improved insulin sensitivity indices such as HOMA-IR, Matsuda Index, and QUICKI (Zhong2022Haploinsufficiency). These individuals also show decreased total cholesterol/HDL-C and APOB/APOA-I ratios, suggesting a reduced risk for atherosclerosis and type 2 diabetes (Zhong2022Haploinsufficiency). The study highlights that reduced CYP8B1 activity leads to increased levels of chenodeoxycholic acid, which enhances skeletal muscle insulin sensitivity (Zhong2022Haploinsufficiency).

In the context of liver cancer, high expression levels of CYP8B1 have been linked to poorer survival outcomes in patients with hepatocellular carcinoma, indicating its potential as a prognostic biomarker (Wang2019Identification). Additionally, a specific single nucleotide polymorphism (SNP) in the CYP8B1 gene, rs3732860, has been associated with an increased risk of gallstone disease in the Chinese Han population (Wang2019Identification). These findings suggest that CYP8B1 plays a significant role in metabolic and liver-related diseases.

## Interactions



## References


[1. (Zhong2022Haploinsufficiency) Shiqi Zhong, Raphael Chèvre, David Castaño Mayan, Maria Corlianò, Blake J. Cochran, Kai Ping Sem, Theo H. van Dijk, Jianhe Peng, Liang Juin Tan, Siddesh V. Hartimath, Boominathan Ramasamy, Peter Cheng, Albert K. Groen, Folkert Kuipers, Julian L. Goggi, Chester Drum, Rob M. van Dam, Ru San Tan, Kerry-Anne Rye, Michael R. Hayden, Ching-Yu Cheng, Shaji Chacko, Jason Flannick, Xueling Sim, Hong Chang Tan, and Roshni R. Singaraja. Haploinsufficiency of cyp8b1 associates with increased insulin sensitivity in humans. Journal of Clinical Investigation, November 2022. URL: http://dx.doi.org/10.1172/jci152961, doi:10.1172/jci152961. This article has 11 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci152961)

[2. (Nebert2013Human) Daniel W. Nebert, Kjell Wikvall, and Walter L. Miller. Human cytochromes p450 in health and disease. Philosophical Transactions of the Royal Society B: Biological Sciences, 368(1612):20120431, February 2013. URL: http://dx.doi.org/10.1098/rstb.2012.0431, doi:10.1098/rstb.2012.0431. This article has 391 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1098/rstb.2012.0431)

[3. (Wang2019Identification) Xiangkun Wang, Xiwen Liao, Chengkun Yang, Ketuan Huang, Tingdong Yu, Long Yu, Chuangye Han, Guangzhi Zhu, Xianmin Zeng, Zhengqian Liu, Xin Zhou, Wei Qin, Hao Su, Xinping Ye, and Tao Peng. Identification of prognostic biomarkers for patients with hepatocellular carcinoma after hepatectomy. Oncology Reports, January 2019. URL: http://dx.doi.org/10.3892/or.2019.6953, doi:10.3892/or.2019.6953. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2019.6953)

[4. (Wang2005Human) Jin Wang, Sinead Greene, Lennart C. Eriksson, Björn Rozell, Eva Reihnér, Curt Einarsson, Gösta Eggertsen, and Mats Gåfvels. Human sterol 12α-hydroxylase (cyp8b1) is mainly expressed in hepatocytes in a homogenous pattern. Histochemistry and Cell Biology, 123(4–5):441–446, May 2005. URL: http://dx.doi.org/10.1007/s00418-005-0779-0, doi:10.1007/s00418-005-0779-0. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00418-005-0779-0)

[5. (Gåfvels1999Structure) Mats Gåfvels, Maria Olin, Bhanu P. Chowdhary, Terje Raudsepp, Ulla Andersson, Bengt Persson, Monica Jansson, Ingemar Björkhem, and Gösta Eggertsen. Structure and chromosomal assignment of the sterol 12α-hydroxylase gene (cyp8b1) in human and mouse: eukaryotic cytochrome p-450 gene devoid of introns. Genomics, 56(2):184–196, March 1999. URL: http://dx.doi.org/10.1006/geno.1998.5606, doi:10.1006/geno.1998.5606. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/geno.1998.5606)